Evidence map›Paper›PMID 41409243›Full record

ArticleFrontiers in oncology2025

Case Report: Advanced colorectal cancer diagnosed and treated with chemotherapy during pregnancy.

Arianna Galante, Marco Cerbone, Giuseppe Sorgente, Pasquale Moramarco, Tommaso Difonzo, Gennaro Cormio, Marco Marinaccio, Raffaello Alfonso, Ettore Cicinelli, Antonella Vimercati

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Arianna GalanteUnit of Obstetrics and Gynecology, Department of Interdisciplinary Medicine (DIM), University of "Aldo Moro", Polyclinic of Bari, Bari, Italy.
Marco CerboneUnit of Obstetrics and Gynecology, Department of Interdisciplinary Medicine (DIM), University of "Aldo Moro", Polyclinic of Bari, Bari, Italy.
Giuseppe SorgenteUnit of Obstetrics and Gynecology, Department of Interdisciplinary Medicine (DIM), University of "Aldo Moro", Polyclinic of Bari, Bari, Italy.
Pasquale MoramarcoUnit of Obstetrics and Gynecology, Department of Interdisciplinary Medicine (DIM), University of "Aldo Moro", Polyclinic of Bari, Bari, Italy.
Tommaso DifonzoUnit of Obstetrics and Gynecology, Department of Interdisciplinary Medicine (DIM), University of "Aldo Moro", Polyclinic of Bari, Bari, Italy.
Gennaro CormioUnit of Obstetrics and Gynecology, Department of Interdisciplinary Medicine (DIM), University of "Aldo Moro", Polyclinic of Bari, Bari, Italy.
Marco MarinaccioUnit of Obstetrics and Gynecology, Department of Interdisciplinary Medicine (DIM), University of "Aldo Moro", Polyclinic of Bari, Bari, Italy.
Raffaello AlfonsoUnit of Obstetrics and Gynecology, Department of Interdisciplinary Medicine (DIM), University of "Aldo Moro", Polyclinic of Bari, Bari, Italy.
Ettore CicinelliUnit of Obstetrics and Gynecology, Department of Interdisciplinary Medicine (DIM), University of "Aldo Moro", Polyclinic of Bari, Bari, Italy.
Antonella VimercatiUnit of Obstetrics and Gynecology, Department of Interdisciplinary Medicine (DIM), University of "Aldo Moro", Polyclinic of Bari, Bari, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Cancer during pregnancy is a rare event and often presents at an advanced stage due to delayed diagnosis. Clinical symptoms are frequently misattributed to normal pregnancy changes, leading to diagnostic challenges. Moreover, concerns regarding fetal safety limit the use of certain imaging modalities and treatment options. Managing cancer in pregnancy requires careful coordination across specialties to balance maternal treatment with fetal preservation. Case-report: We present the case of a pregnant woman diagnosed in the second trimester with advanced metastatic colorectal cancer. The disease involved multiple intra-abdominal sites, and the patient was managed through a multidisciplinary approach. Chemotherapy with FOLFOX scheme was administered during the second and third trimester of pregnancy, leading to a favorable clinical and radiologic response. Delivery was planned at term, with no complications for the newborn. Postpartum oncologic management was continued without delay. Conclusion: This case highlights the importance of individualized care in such complex scenarios and the feasibility and safety of administering chemotherapy during pregnancy.

Indexed as

cancerchemotherapychemotherapy in pregnancycolorectal cancerpregnancypregnancy associated cancer

Identifiers

PMID41409243
PMCPMC12705379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.